MedTrace Logo

The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa

NCT05919316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-05-22

No results posted yet for this study

Summary

The aim of this study to compare the efficacy of Rhinophototherapy to Intranasal Corticosteroids on the the nasal mucosa of allergic rhinitis patients. The main question to answer is: Does intranasal phototherapy reduce inflammation in the tissue biopsy of the inferior turbinate mucosa compared to intranasal steroids?

The hypothesis for this study is Intranasal phototherapy will reduce mucosal inflammation without mucosal damage and is comparable to intranasal steroids in allergic rhinitis patients

Conditions

Interventions

DEVICE

Rhinophototherapy

Intranasal rhinophotometer to be used at home for 4.5 minutes three times daily for 14 days

DRUG

Nasonex Nasal Spray

50mcg/dose, 2 sprays each nostril (morning or evening) once daily for 14 days

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Hardip Singh Gendeh · Otorhinolaryngology Department, Head and Neck Surgery, Faculty of Medicine, UKM Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2024-10-10
Completion
2024-11-10

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05919316 on ClinicalTrials.gov